AUSTRALIAN PRODUCT INFORMATION - SPIKEVAX XBB.1.5 (ANDUSOMERAN) COVID-19 VACCINE
SPIKEVAX XBB.1.5 (andusomeran) COVID-19 Vaccine is indicated for:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older.
AUSTRALIAN PRODUCT INFORMATION –
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (ELASOMERAN/DAVESOMERAN) COVID-19 VACCINE
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 Vaccine is indicated for:
As a booster dose for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against COVID-19.
Spikevax (previously COVID‑19 Vaccine Moderna)
SPIKEVAX (elasomeran) COVID-19 Vaccine is indicated for:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 years of age and older.
SPIKEVAX (elasomeran) COVID-19 Vaccine has provisional approval for the indication below:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 months of age to <6 years of age.
Tools
Contact Moderna
9am-7pm AEST Mon-Fri
Email for inquiries: WeCare@modernatx.com